← Open Payments lookup

CHARLENE JO NARDO: Open Payments

NPI 1477249761 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,282 in 57 payments from 12 companies in 2025. Trend: 2023 $452 · 2024 $963 · 2025 $1,282

Food & beverage: $1,282
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$259
E.R. Squibb & Sons, L.L.C.11$229
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$183
ABBVIE INC.8$155
Otsuka America Pharmaceutical, Inc.6$130
Alkermes, Inc.4$82
Almatica Pharma LLC3$72
Takeda Pharmaceuticals U.S.A., Inc.2$42
Indivior Inc.1$38
Teva Pharmaceuticals USA, Inc.2$36

Products named: INGREZZA, COBENFY, CAPLYTA, VRAYLAR, REXULTI, ARISTADA, LOREEV XR, ABILIFY ASIMTUFII.

Industry payments across NV — which companies pay providers there.